Parkinsons Concierge

Who are we?

At Parkinson’s Concierge we want to promote Patient Engagement, Involved,  and have the opportunity to accelerate the desperate need for a Cure.

It is now evident that to find a Cure for Parkinson’s everyone needs to be involved and partnering with each other.

At Parkinson’s Concierge we are becoming a voice for People with Parkinson’s.

We all live with Parkinson's.

We want to be involved in all aspects of finding a cure for Parkinson’s and believe it is the way forward to be the final link between Tech companies/ Pharma/Medical Industry Professionals.

Inclusion is required in the following areas

Involved with the strategic development of patient and professional relationships

Enable us to contribute to funding for clinical research trials for Parkinson’s

We have a particular interest in engaging with early detection/research companies

Connecting and communicating with stakeholders

Identifying key relationships between all business partnerships

We are Advocates of the Parkinson’s Movement

We sit on the Panel of Parkinson’s Steering Committees at various hospitals for research

Inclusion with clinical trials where Patients can be involved with execution through to completion by providing tech data (that is so desperately needed) from the people who live with Parkinson’s

What can we offer you?

Within our team we have people with expertise in the areas of drug development, clinical trial operations, and strategic planning, relationship management, awareness creation, & training

Our biggest USP is of course, we ALL have Parkinson’s

We are 100% committed to devoting the rest of our lives to improving the lives of people affected by Parkinson’s

Our Unique Business Model can be rolled out Worldwide with the right investment and backing

We also have experience working with multiple vendors

We possess strong planning and tracking skills

We are customer focused, well organised, detail oriented

We can demonstrate excellent time, priority, and self-management skills

Strong project-management skills

Effective leadership skills and proven ability to foster team productivity and cohesiveness.

Excellent communication skills with the ability to add value to your organisation from a Patient perspective

We have the proven ability to negotiate and influence others


  • Acting as Parkinson’s Advocates
  • Advisors on problems in Parkinson’s
  • Bid writing for funding purposes
  • Design of questionnaires
  • Organising focus groups
  • UX design
  • Report writing
  • Public Speaking
  • Creating Awareness at Corporate Events
  • Partnering with organisations who can make a difference

What type of impact can we make?

Our unique business model offers experience, talents and a perspective which can make a vital contribution to innovative products & research methods that the Medical industry are developing for Parkinson’s. Therefore, we can take part in improving the lives of people everywhere suffering from this incurable disease. We want to be part of the change that is needed in order to accelerate finding a cure.

Let’s help the Medical industry to help us – The People with Parkinson’s

Company Type
Twitter Account
News Page URL
Click here

Pebmond Associates

From drug discovery to commercialisation - we support the full spectrum.

Business Development and Licensing - Need support to acquire, divest or license a product or project? That's what we do. Regulatory Affairs, Pharmacovigilance - If you need support with your regulatory affairs, regulatory strategy or pharmacovigilance needs, we can arrange this through our trusted partner organisation. Wide Network - Projects at initial scientific concepts? Products at commercialisation and reimbursement stage? Our partners will help. Due Diligence and Auditing - Looking for support for due diligence, or auditing of partners? We can arrange all this.

Company Type
News Page URL
Click here

Pharmaceutical Licensing Group United Kingdom

The Pharmaceutical Licensing Group, in the UK, has been established for 30 years and is the professional association for those active in pharmaceutical and biotechnology business development and licensing. 

There are around 200 members in the UK and over a 1000 in affiliated groups in Europe, Canada and Japan. All sectors of the industry are represented including multinationals, medium and small pharmaceutical companies, biotechnology, generic and consumer companies. 

The PLG is a not-for-profit organisation and is managed by a committee of licensing and business development executives from member companies. Details of the Committee members and how to contact them can be found by following the Committee link. 

The PLG organises meetings within local countries, a bi-annual European meeting and a bi-annual International meeting. Details of all meetings can be found on the Events page and by linking to other PLG sites on the European page. 

Precision for Medicine

Precision for Medicine, Oncology and Rare Disease is proud to offer the first comprehensive, fully integrated clinical development solution. We are devoted exclusively to oncology and rare disease, and our teams are passionate about improving the lives of these patients. By combining the progressive science of biomarkers and analytics with our excellence in complex clinical trial execution, we help innovators to invest wisely, discover value sooner and optimize the returns from research.

Contact Precision for Medicine, Oncology and Rare Disease via their website

Company Type
Twitter Account
News Page URL
Click here

Quotient Sciences

Quotient Sciences is a drug development and manufacturing accelerator providing integrated services across the entire development pathway. Everything we do is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast.


Sareum is a specialist drug development company delivering targeted small molecule therapeutics to improve the treatment of cancer and autoimmune diseases. The Company aims to generate value through licensing its candidates to international pharmaceutical and biotechnology companies at the preclinical or early clinical trials stage.


Sareum is advancing internal programmes focused on distinct dual tyrosine kinase 2 (TYK2) / Janus kinase 1 (JAK1) inhibitors through preclinical development as therapies for autoimmune diseases, including the ‘cytokine storm’ immune system overreaction to Covid-19 and other viral infections, (SDC-1801) and cancer immunotherapy (SDC-1802).

Sareum is based in Cambridge, UK and listed on the AIM market of the London Stock Exchange, trading under the ticker SAR.

Company Type
Twitter Account
News Page URL
Click here


Scendea was founded as a result of a management buyout of the product development and regulatory consulting function of a clinical research organisation. Our origin dates back over 20 years, with involvement in over 1,000 development programmes.

Scendea’s expert team delivers strategic and operational support in the fields of quality/CMC, non-clinical/toxicology, clinical/medical and regulatory to successfully guide products from early development to marketing approval. 

A combination of scientific excellence, industry experience, commercial awareness and a collaborative approach allow our expert team to solve complex issues associated with medicinal product development. Scendea has team members based in the UK, Ireland, the Netherlands and the US, who deliver innovative and high-quality solutions aligned to jurisdiction-specific regulatory requirements.

At Scendea we collaborate, innovate, and together with our clients, we succeed.

Company Type
Twitter Account
News Page URL
Click here

Science Entrepreneur Club

The Science Entrepreneur Club (SEC) is a London based non-profit organisation of curious minds that aims to explore and unite the life science ecosystem by educating, inspiring and connecting. We give scientists, innovators and startups, with a focus on biotech, pharma, medtech, bioengineering, biosustainability or related, a network and a unique platform to showcase their innovative technologies, find investors, meet like-minded people and accelerate their company.

Company Type
Twitter Account
News Page URL
Click here


Sekisui Diagnostics, a global provider of innovative medical diagnostics to physicians and laboratories, has been committed to improving the lives of patients for over 30 years. We continue to invest in new diagnostic products in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems. We are a leading provider of rapid tests in the U.S., and high throughput coagulation systems in Japan. We develop, manufacture, and supply over 1.7 billion tests each year to the global healthcare market through direct sales, our commercial distribution networks and our partners.

Company Type
Twitter Account
News Page URL
Click here

Silence Therapeutics

Silence Therapeutics develops a new generation of medicines by harnessing the body’s natural mechanism of RNA interference, or RNAi, within its cells.

Our proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. Using our enabling delivery systems, we have achieved an additional level of specificity by delivering our therapeutic RNA molecules exclusively to target cells. Silence’s proprietary RNA chemistries and delivery systems are designed to improve the stability of our molecules and enhance effective delivery to target cells, providing a powerful modular technology well suited to tackle life-threatening diseases.

Company Type
Twitter Account
News Page URL
Click here